Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma

Abstract

The heterogeneous basal expression of HLA class II antigens and/or APM components in melanoma cells is caused by distinct molecular mechanisms and has clinical relevance.